Skip to main content

Catalio Capital Management, LP

13F filer · CIK 0001958125
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$532MU.S. long equity reported on 13F
Positions3910 new · 12 closed
Net flow last quarter-$48.7MBuys minus sells
Top 10 positions weight56.7%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 202639 positions
AVLNAvalyn Pharma Inc.$55.2M10.37%3.78%NewQ2 2026
JNJJohnson & Johnson$35.3M6.63%0.01%Not reportedQ4 2025
GILDGilead Sciences, Inc.$34M6.39%0.02%+64.3%Q2 2025
BBIOBridgeBio Pharma, Inc.$33.9M6.37%0.23%+5.3%Q4 2024
SNDXSyndax Pharmaceuticals Inc$26.6M4.99%1.36%+16.5%Q1 2025
DFTXDefinium Therapeutics, Inc.$26.5M4.97%0.42%-45.8%Q1 2026
BMYBristol Myers Squibb Co$23.8M4.47%0.02%-1.9%Q4 2024
PBLSParabilis Medicines, Inc.$22.6M4.24%0.68%NewQ2 2026
NTRANatera, Inc.$22.3M4.19%0.06%+15.9%Q2 2025
INCYIncyte Corp$21.7M4.08%0.10%+5.2%Q1 2026
SEPNSepterna, Inc.$18M3.37%1.17%+82.1%Q4 2024
MLYSMineralys Therapeutics, Inc.$17.5M3.29%0.73%+47.8%Q4 2025
HTFLHeartflow, Inc.$17.1M3.21%0.67%+44.5%Q4 2025
CRVSCorvus Pharmaceuticals, Inc.$16.1M3.03%1.28%+21.2%Q1 2026
GPCRStructure Therapeutics Inc.$14.8M2.79%0.13%+8.3%Q4 2024
PTGXProtagonist Therapeutics, Inc$13.1M2.46%0.17%NewQ2 2026
IRONDisc Medicine, Inc.$11.7M2.19%0.42%+29.6%Q4 2024
EWEdwards Lifesciences Corp$11.3M2.12%0.02%-13.7%Q4 2024
AXSMAxsome Therapeutics, Inc.$10.6M1.99%0.08%NewQ2 2026
RAREUltragenyx Pharmaceutical Inc.$10.6M1.98%0.32%-62.8%Q2 2025
KLRAKailera Therapeutics, Inc.$10.3M1.94%0.36%NewQ2 2026
KPTIKaryopharm Therapeutics Inc.$9.19M1.73%4.15%+4.8%Q4 2024
ODTXOdyssey Therapeutics, Inc.$8.57M1.61%0.96%NewQ2 2026
ASNDAscendis Pharma A/S$8.47M1.59%0.05%-75.4%Q4 2024
KARDKardigan, Inc.$7.45M1.40%0.33%NewQ2 2026
ELDNEledon Pharmaceuticals, Inc.$6.68M1.26%2.10%+3.4%Q3 2025
FDMT4D Molecular Therapeutics, Inc.$6.27M1.18%0.85%NewQ2 2026
MANEVeradermics, Inc$5.64M1.06%0.11%-73.6%Q1 2026
DYNDyne Therapeutics, Inc.$5.44M1.02%0.15%-13.4%Q4 2025
GUTSFractyl Health, Inc.$4.9M0.92%3.89%+12.3%Q4 2024
IMCRImmunocore Holdings plc$4.7M0.88%0.29%+75.5%Q1 2026
DNTHDianthus Therapeutics, Inc.$3.21M0.60%0.06%-94.1%Q4 2024
BBOTBridgeBio Oncology Therapeutics, Inc.$2.43M0.46%0.40%Not reportedQ4 2025
TARAProtara Therapeutics, Inc.$1.99M0.37%0.88%-10.3%Q4 2024
HYPRHyperfine, Inc.$1.78M0.33%Not reportedNot reportedQ4 2024
ATAIAtaiBeckley Inc.$1.04M0.19%0.05%Not reportedQ1 2026
MGXMetagenomi Therapeutics, Inc.$630K0.12%1.40%Not reportedQ4 2024
OMOutset Medical, Inc.$511K0.10%0.63%Not reportedQ1 2025
FTHFaeth Therapeutics, Inc.$368K0.07%0.06%Not reportedQ2 2025
Q1 2026Reported May 15, 202641 positions
DNTHDianthus Therapeutics, Inc.$47M9.82%1.03%-14.3%Q4 2024
BBIOBridgeBio Pharma, Inc.$32.1M6.70%0.22%Not reportedQ4 2024
ASNDAscendis Pharma A/S$29.5M6.17%0.21%+8.3%Q4 2024
BMYBristol Myers Squibb Co$25.5M5.33%0.02%-35.1%Q4 2024
SNDXSyndax Pharmaceuticals Inc$24.4M5.09%1.18%-12.8%Q1 2025
GILDGilead Sciences, Inc.$22.8M4.77%0.01%-43.4%Q2 2025
TERNTerns Pharmaceuticals, Inc.$21.6M4.50%0.35%+198.7%Q4 2025
DFTXDefinium Therapeutics, Inc.$19.6M4.10%1.00%NewQ1 2026
SLNOSoleno Therapeutics Inc$19.3M4.04%1.12%+60.4%Q1 2025
BSXBoston Scientific Corp$18.8M3.92%0.02%-17.0%Q4 2024
RAREUltragenyx Pharmaceutical Inc.$17.8M3.72%0.87%+423.4%Q2 2025
INCYIncyte Corp$17.1M3.58%0.09%NewQ1 2026
CYTKCytokinetics Inc$14.2M2.97%0.18%-16.6%Q4 2024
NTRANatera, Inc.$14.2M2.96%0.05%+13.9%Q2 2025
CRVSCorvus Pharmaceuticals, Inc.$13M2.73%1.06%NewQ1 2026
GPCRStructure Therapeutics Inc.$12.3M2.57%0.12%+1.0%Q4 2024
MLYSMineralys Therapeutics, Inc.$11.9M2.48%0.53%+32.3%Q4 2025
EWEdwards Lifesciences Corp$11.6M2.42%0.03%-22.7%Q4 2024
MANEVeradermics, Inc$11M2.29%0.46%NewQ1 2026
ADPTAdaptive Biotechnologies Corp$10M2.10%0.45%-12.0%Q1 2025
HTFLHeartflow, Inc.$9.82M2.05%0.47%+254.5%Q4 2025
KALVKalVista Pharmaceuticals, Inc.$8.59M1.79%0.83%NewQ1 2026
QUREuniQure N.V.$8.03M1.68%0.78%+70.3%Q4 2024
IRONDisc Medicine, Inc.$7.86M1.64%0.32%+11.4%Q4 2024
SEPNSepterna, Inc.$7.07M1.48%0.66%Not reportedQ4 2024
ABVXAbivax S.A.$5.25M1.10%0.06%-52.1%Q3 2025
DYNDyne Therapeutics, Inc.$5.13M1.07%0.17%-45.6%Q4 2025
ELDNEledon Pharmaceuticals, Inc.$5.05M1.06%2.16%+30.2%Q3 2025
KPTIKaryopharm Therapeutics Inc.$5M1.04%3.98%+527.8%Q4 2024
SUPNSupernus Pharmaceuticals, Inc.$3.21M0.67%0.11%-75.9%Q3 2025
TARAProtara Therapeutics, Inc.$3.02M0.63%1.05%-59.9%Q4 2024
PHATPhathom Pharmaceuticals, Inc.$2.75M0.58%0.31%-64.6%Q2 2025
NAMSNewAmsterdam Pharma Co N.V.$2.67M0.56%0.07%NewQ1 2026
TYRATyra Biosciences, Inc.$2.58M0.54%0.11%NewQ1 2026
IMCRImmunocore Holdings plc$2.54M0.53%0.17%NewQ1 2026
GUTSFractyl Health, Inc.$2.51M0.53%3.46%Not reportedQ4 2024
HYPRHyperfine, Inc.$1.43M0.30%Not reportedNot reportedQ4 2024
MGXMetagenomi Therapeutics, Inc.$709K0.15%1.41%Not reportedQ4 2024
ATAIAtaiBeckley Inc.$697K0.15%0.05%NewQ1 2026
FTHFaeth Therapeutics, Inc.$464K0.10%1.10%Not reportedQ2 2025
OMOutset Medical, Inc.$454K0.09%0.64%Not reportedQ1 2025
Q4 2025Reported Feb 17, 202644 positions
GILDGilead Sciences, Inc.$35.5M6.28%0.02%Not reportedQ2 2025
BMYBristol Myers Squibb Co$34.9M6.18%0.03%Not reportedQ4 2024
BSXBoston Scientific Corp$34.4M6.07%0.02%+37.1%Q4 2024
BBOTBridgeBio Oncology Therapeutics, Inc.$31.4M5.55%0.51%NewQ4 2025
LLYELI LILLY & Co$27.9M4.92%0.00%-54.8%Q1 2025
DNTHDianthus Therapeutics, Inc.$26.9M4.76%1.51%-2.1%Q4 2024
ASNDAscendis Pharma A/S$25.4M4.49%0.19%-17.7%Q4 2024
SNDXSyndax Pharmaceuticals Inc$25.1M4.44%1.37%-25.9%Q1 2025
JNJJohnson & Johnson$25M4.42%0.01%NewQ4 2025
REGNRegeneron Pharmaceuticals, Inc.$23M4.07%0.03%-15.7%Q1 2025
GPCRStructure Therapeutics Inc.$17.6M3.11%0.12%-61.2%Q4 2024
SLNOSoleno Therapeutics Inc$16.7M2.95%0.69%-13.8%Q1 2025
CYTKCytokinetics Inc$16.4M2.90%0.21%-42.8%Q4 2024
EWEdwards Lifesciences Corp$15.9M2.82%0.03%Not reportedQ4 2024
ISRGIntuitive Surgical Inc$15.4M2.72%0.01%-61.9%Q4 2024
NTRANatera, Inc.$14.3M2.52%0.04%-58.0%Q2 2025
ADPTAdaptive Biotechnologies Corp$13.3M2.36%0.53%-7.2%Q1 2025
ABVXAbivax S.A.$13.3M2.35%0.13%-39.2%Q3 2025
SUPNSupernus Pharmaceuticals, Inc.$12.8M2.26%0.45%-10.3%Q3 2025
GUTSFractyl Health, Inc.$12.1M2.14%3.58%+5.3%Q4 2024
MLYSMineralys Therapeutics, Inc.$12M2.13%0.41%NewQ4 2025
PHATPhathom Pharmaceuticals, Inc.$11.6M2.05%0.98%-38.1%Q2 2025
ADMAAdma Biologics, Inc.$10.3M1.82%0.24%-17.5%Q4 2024
ACLXArcellx, Inc.$10.2M1.80%0.27%NewQ4 2025
DYNDyne Therapeutics, Inc.$10.2M1.80%0.32%NewQ4 2025
IRONDisc Medicine, Inc.$8.77M1.55%0.29%-49.0%Q4 2024
OCULOcular Therapeutix, Inc$8.67M1.53%0.33%NewQ4 2025
SEPNSepterna, Inc.$8.21M1.45%0.66%Not reportedQ4 2024
TARAProtara Therapeutics, Inc.$7.71M1.36%2.70%-3.6%Q4 2024
QUREuniQure N.V.$6.9M1.22%0.46%+1.9%Q4 2024
OLMAOlema Pharmaceuticals, Inc.$6.68M1.18%0.33%NewQ4 2025
TERNTerns Pharmaceuticals, Inc.$5.53M0.98%0.12%NewQ4 2025
RAREUltragenyx Pharmaceutical Inc.$3.74M0.66%0.17%-44.2%Q2 2025
HTFLHeartflow, Inc.$3.32M0.59%0.13%NewQ4 2025
GRALGRAIL, Inc.$2.59M0.46%0.08%-78.0%Q3 2025
FULCFulcrum Therapeutics, Inc.$2.28M0.40%0.30%Not reportedQ1 2025
BLLNBillionToOne, Inc.$2.09M0.37%0.23%NewQ4 2025
ELDNEledon Pharmaceuticals, Inc.$1.9M0.34%1.67%+18.7%Q3 2025
HYPRHyperfine, Inc.$1.29M0.23%Not reported+92.8%Q4 2024
PVLAPalvella Therapeutics, Inc.$1.09M0.19%0.08%-13.0%Q3 2025
KPTIKaryopharm Therapeutics Inc.$1.05M0.19%0.78%Not reportedQ4 2024
MGXMetagenomi Therapeutics, Inc.$857K0.15%1.41%Not reportedQ4 2024
OMOutset Medical, Inc.$439K0.08%0.65%Not reportedQ1 2025
FTHFaeth Therapeutics, Inc.$157K0.03%1.17%Not reportedQ2 2025
Q3 2025Reported Nov 14, 202537 positions
LLYELI LILLY & Co$43.8M8.09%0.01%+6.4%Q1 2025
ABBVAbbVie Inc.$35.9M6.63%0.01%NewQ3 2025
BBIOBridgeBio Pharma, Inc.$32.3M5.98%0.32%-32.9%Q4 2024
ISRGIntuitive Surgical Inc$31.9M5.90%0.02%+25.9%Q4 2024
ASNDAscendis Pharma A/S$28.8M5.33%0.24%-19.4%Q4 2024
SLNOSoleno Therapeutics Inc$28.3M5.23%0.78%+2.0%Q1 2025
DNTHDianthus Therapeutics, Inc.$26.3M4.86%1.56%-10.6%Q4 2024
BSXBoston Scientific Corp$25.7M4.75%0.02%+14.8%Q4 2024
SNDXSyndax Pharmaceuticals Inc$24.8M4.59%1.86%-23.3%Q1 2025
CYTKCytokinetics Inc$24.8M4.59%0.38%-24.9%Q4 2024
NTRANatera, Inc.$23.9M4.42%0.11%+52.5%Q2 2025
REGNRegeneron Pharmaceuticals, Inc.$19.9M3.67%0.04%Not reportedQ1 2025
GPCRStructure Therapeutics Inc.$18.3M3.37%0.36%-2.8%Q4 2024
QUREuniQure N.V.$16.5M3.05%0.46%-32.2%Q4 2024
IRONDisc Medicine, Inc.$14.3M2.65%0.62%+606.2%Q4 2024
ABVXAbivax S.A.$13.8M2.54%0.26%NewQ3 2025
SUPNSupernus Pharmaceuticals, Inc.$13.7M2.54%0.50%NewQ3 2025
EXKEndeavour Silver Corp$13.6M2.52%0.09%Not reportedQ4 2024
PHATPhathom Pharmaceuticals, Inc.$13.3M2.46%1.59%+67.9%Q2 2025
ADPTAdaptive Biotechnologies Corp$13.2M2.45%0.58%-36.6%Q1 2025
RNAMAvidity Biosciences, Inc.$11.5M2.12%0.18%NewQ3 2025
ADMAAdma Biologics, Inc.$10M1.86%0.29%+20.2%Q4 2024
RAREUltragenyx Pharmaceutical Inc.$8.76M1.62%0.30%+36.5%Q2 2025
GUTSFractyl Health, Inc.$8.29M1.53%3.94%+2333.9%Q4 2024
GRALGRAIL, Inc.$8.16M1.51%0.38%NewQ3 2025
TARAProtara Therapeutics, Inc.$6.53M1.21%3.89%-7.7%Q4 2024
SEPNSepterna, Inc.$5.54M1.02%0.66%Not reportedQ4 2024
CDTXCidara Therapeutics, Inc.$5.11M0.94%0.18%NewQ3 2025
KYTXKyverna Therapeutics, Inc.$3.52M0.65%1.34%Not reportedQ4 2024
ELDNEledon Pharmaceuticals, Inc.$2.75M0.51%1.77%NewQ3 2025
OMOutset Medical, Inc.$1.67M0.31%0.66%-29.0%Q1 2025
MGXMetagenomi Therapeutics, Inc.$1.25M0.23%1.41%Not reportedQ4 2024
HYPRHyperfine, Inc.$993K0.18%Not reported-9.9%Q4 2024
MLTXMoonLake Immunotherapeutics$955K0.18%0.25%-18.1%Q1 2025
KPTIKaryopharm Therapeutics Inc.$935K0.17%1.64%-2.1%Q4 2024
PVLAPalvella Therapeutics, Inc.$753K0.14%0.11%NewQ3 2025
FTHFaeth Therapeutics, Inc.$139K0.03%1.17%Not reportedQ2 2025
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.